Samsung Bioepis Goes After Lucentis With 40% Cheaper Byooviz Launch In US

Delivers Global First With Ranibizumab Biosimilar Launch Through Partner Biogen

 
• By David Wallace
  
Eye closeup dollar symbol
The first ophthalmic biosimilar offers significant savings over Lucentis • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products